Yi, Yong Weon <br/><br/>
Targeting mutant p53 by a SIRT1 activator YK-3-237 inhibits the proliferation of triple-negative breast cancer cells.  [electronic resource] 

 -  Oncotarget  Jul 2013 
 - 984-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.1070  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation--drug effects<br/>Apoptosis--physiology<br/>Boronic Acids--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Chalcones--pharmacology<br/>Female<br/>Gene Expression--drug effects<br/>Humans<br/>Molecular Targeted Therapy<br/>RNA, Small Interfering--genetics<br/>Sirtuin 1--genetics<br/>Transfection<br/>Triple Negative Breast Neoplasms--drug therapy<br/>Tumor Suppressor Protein p53--genetics